Hayashi T, Hikichi M, Yukitake J, Wakatsuki T, Nishio E, Utsumi T, Harada N. Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells. Oncotarget. 2018. 9. 34. 23451-23461
T Hayashi, M Hikichi, J Yukitake, N Harada, T Utsumi. Estradiol suppresses phosphorylation of -ERα serine 167 through upregulation of P P2A in breast can cer cells. Oncology Letters. 2017. 14. 6. 8060-8065
N Kobayashi, M Hikichi, K Ushimado, A Sugioka, Y Kiriyama, M Kuroda, T Utsumi. Differences in subtype distribution between screen-detected and symptomatic inva sive breast cancer and their impact on survival. Clinical and Translational Oncology. 2017
Kobayashi N, Kiriyama Y, Hikichi M, Miyajima S, Kuroda M, Utsumi T. PREDICTIVE SIGNIFICANCE OF BREAST CANCER SUBTYPES IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY. The Breast. 2013. 22. 1. S103
Kobayashi N, Hikichi M, Miyajima S, Utsumi T. Subtypes of screen-detected invasive breast cancer and symptomatic invasive breast cancer and their impact on survival. Cancer Research. 2012. 72. 24. Supplement 3:291s
Kobayashi N, Ushimado K, Hikichi M, Miyajima S, Utsumi T. Comparison Between Screen-detected Invasive Breast Cancer and Symptomatic Breast Cancer According to Immunohistochemical Intrinsic Subtypes. European Journal of Cancer. 2012. 48. 1. S85
Utsumi T, Kobayashi N, Hikichi M, Miyajima S. Predictive Factors for Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with a Positive Sentinel Lymph Node. European Journal of Surgical Oncology. 2012. 38. 9. 816
A pilot study to investigate high-sensitivity cardiac troponin I (hscTnI) and high-sensitivity cardiac troponin T (hscTnT) for the prediction of cardiotoxicity in women with breast cancer treated with doxorubicin or trastuzumab.
(4TH ESO-ESMO BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONFERENCE(BCY4) , 2018. 2018)
Clinicopathological features of young women (≤39 years old) with invasive breast cancer.
(THE 11TH EUROPEAN BREAST CANCER CONFERENCE, 2018. 2018)